https://doi.org/10.1002/14651858.CD010216.pub10
The material in this section has been supplied by the author(s) for publication under a Licence for Publication and the author(s) are solely responsible for the material. Cochrane has reviewed this material, but Cochrane has not copyedited, formatted or proofread. Cochrane accordingly gives no representations or warranties of any kind in relation to, and accepts no liability for any reliance on or use of, such material.
|
Methods |
RCT Setting: dental surgery, West Java, Indonesia |
|
Participants |
Target sample 34 Inclusion criteria: 18 to 65 years, smoke CC Exclusion criteria: acute illness that required treatment (subjects who had a viral infection) within 4 weeks before the enrolment visit, having oral soft tissue disease or any type of gingival overgrowth other than those caused by plaque, suffering from periodontitis, having a history of tooth loss due to periodontitis, being treated with anticoagulant therapy in the previous 6 months, using prostheses or orthodontic appliances, history of alcoholism or drug/chemical abuse, taking any drug or substance (other than tobacco) that interferes with the cyclooxygenase pathway (e.g. anti-inflammatory drugs including aspirin and ibuprofen) in the 14 days prior to the enrolment visit, taking antibiotics in the 14 days prior to the enrolment visit, breastfeeding or pregnant women. |
|
Interventions |
2 arms EC vs control (continued CC use) |
|
Outcomes |
Investigating effect of switching to vaping from tobacco cigarettes on gingival health |
|
Notes |
New to 2024 Contact: Indra Mustika, Universitas Padjadjaran, West Java Indonesia. Email: indra.mustika@unpad.ac.id |
|
Methods |
RCT, 2-arm, non-blinded Setting: dental surgery, West Java, Indonesia |
|
Participants |
Target sample 34 Inclusion criteria: 18 to 65, current CC use Exclusion criteria: having an acute illness that required treatment (subjects who had a viral infection) within 4 weeks before the enrolment visit, having oral soft tissue disease or any type of gingival overgrowth other than those caused by plaque, suffering from periodontitis, having a history of tooth loss due to periodontitis, being treated with anticoagulant therapy in the previous 6 months, using prostheses or orthodontic appliances, history of alcoholism or drug/chemical abuse, taking any drug or substance (other than tobacco) that interferes with the cyclooxygenase pathway (e.g. anti-inflammatory drugs including aspirin and ibuprofen) in the 14 days prior to the enrolment visit, taking antibiotics in the 14 days prior to the enrolment visit, breastfeeding or pregnant women |
|
Interventions |
Intervention: EC Control: continued CC use |
|
Outcomes |
Impact of switching from tobacco smoking to vape use on the number of buccal and palatal mucosal micronucleus cells |
|
Notes |
New to 2024 Contact: Indra Mustika, Universitas Padjadjaran, West Java Indonesia. Email: indra.mustika@unpad.ac.id |
CC: combustible cigarette
EC: electronic cigarette
RCT: randomized controlled trial